The Tithonia Group

Tithonia Group is an entrepreneurial life sciences holding company dedicated to allowing stranded innovation to exist and thrive within the pharmaceutical industry. The group's primary purpose is to improve patient access to proven medicines on a global scale. This is achieved through a unique structure comprised of two sister companies, Simple Pharma and Androlabs, each with a distinct but complementary strategy. Tithonia Group operates on the principle of working smarter, not harder, by employing innovative and lean processes to drive success and maintain the highest standards of quality and patient safety. The group fosters a culture of knowledge, transparency, agency, and humility, empowering its teams to make a significant impact.

The group's operations are managed through its two core brands. Simple Pharma, founded in 2019, aims to be the best home for proven pharmaceutical products by providing integrated, digitally enabled, end-to-end operations, distribution, and compliance services. It addresses the significant overspending in pharma operations, which can jeopardize product success and create healthcare system inefficiencies. Simple Pharma manages a substantial number of marketing authorisations across numerous countries, handling large volumes of units monthly. The other brand, Androlabs, launched in February 2021, is the first global pharmaceutical company exclusively focused on men's health. Its mission is to close the male life expectancy gap by increasing knowledge and awareness of overlooked men's health issues. Androlabs commercialises products for conditions like low testosterone and erectile dysfunction in over 20 countries, re-evaluating the traditional pharma model by prioritising targeted, science-led engagement with healthcare professionals.